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Abstract
SHARPIN is a key regulator of NFKB and integrin signaling. Mice lacking Sharpin develop a phenotype known as chronic
proliferative dermatitis (CPDM), typified by progressive epidermal hyperplasia, apoptosis of keratinocytes, cutaneous and
systemic eosinophilic inflammation, and hypoplasia of secondary lymphoid organs. Rag12/2 mice, which lack mature B and
T cells, were crossed with Sharpin2/2 mice to examine the role of lymphocytes in CDPM. Although inflammation in the
lungs, liver, and joints was reduced in these double mutant mice, dermatitis was not reduced in the absence of functional
lymphocytes, suggesting that lymphocytes are not primary drivers of the inflammation in the skin. Type 2 cytokine
expression is increased in CPDM. In an attempt to reduce this aspect of the phenotype, Il4ra2/2 mice, unresponsive to both
IL4 and IL13, were crossed with Sharpin2/2 mice. Double homozygous Sharpin2/2, Il4ra2/2 mice developed an exacerbated
granulocytic dermatitis, acute system inflammation, as well as hepatic necrosis and mineralization. High expression of
CHI3L4, normally seen in CPDM skin, was abolished in Sharpin2/2, Il4ra2/2 double mutant mice indicating the crucial role of
IL4 and IL13 in the expression of this protein. Cutaneous eosinophilia persisted in Sharpin2/2, Il4ra2/2 mice, although
expression of Il5 mRNA was reduced and the expression of Ccl11 and Ccl24 was completely abolished. TSLP and IL33 were
both increased in the skin of Sharpin2/2 mice and this was maintained in Sharpin2/2, Il4ra2/2 mice suggesting a role for
TSLP and IL33 in the eosinophilic dermatitis in SHARPIN-deficient mice. These studies indicate that cutaneous inflammation
in SHARPIN-deficient mice is autoinflammatory in nature developing independently of B and T lymphocytes, while the
systemic inflammation seen in CPDM has a strong lymphocyte-dependent component. Both the cutaneous and systemic
inflammation is enhanced by loss of IL4 and IL13 signaling indicating that these cytokines normally play an anti-
inflammatory role in SHARPIN-deficient mice.
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Introduction
SHARPIN was recently identified as a component of the linear
ubiquitin chain assembly complex (LUBAC) which also contains
RNF31 (previously HOIP) and RBCK1 (previously HOIL1)
[1,2,3]. This ubiquitination complex is an important component
of the NFKB signaling pathway which is a critical regulator of
inflammation, the immune response, and lymphoid tissue devel-
opment [2,3,4]. In addition, SHARPIN is a negative regulator of
integrin beta 1 (ITGB1) [5], a component of cell adhesion and cell
recognition in a variety of processes including embryogenesis,
hemostasis, tissue repair, immune response, and tumor metastasis.
The physiological importance of SHARPIN is evident in the
complex phenotype seen in SHARPIN-deficient mice. A sponta-
neous mutation in exon 1 of Sharpin resulted in the chronic
proliferative dermatitis (CPDM) mouse mutant (C57BL/KaLa-
wRij-Sharpincpdm/RijSunJ, hereafter referred to as Sharpincpdm) [6,7].
These mice develop systemic inflammation characterized by
accumulation of eosinophils, macrophages, and neutrophils, most
prominently in the skin, but also other tissues including the lung,
liver, esophagus, and joints. Homozygotes have defective lym-
phoid organs characterized by absence of follicles and marginal
zones in the spleen and absence of follicles in lymph nodes [8].
Peyer’s patches are initially formed in neonatal mice, but regress
after two weeks of age and are absent in adult mice [9].
Furthermore, SHARPIN-deficient mice have a defective TH1
immune response and a shift towards a TH2 response [10,11].
The phenotype of Sharpincpdm mice has striking similarities to
autoinflammatory diseases in human patients with inflammatory
skin disease. Prototypical autoinflammatory diseases such as TNF-
receptor associated syndrome (TRAPS) and familial Mediterra-
nean fever (FMF) are characterized by dermatitis, arthritis,
serositis, and fever in the absence of evidence of a role for
autoantibodies and self-reactive T cells [12]. Previous studies in
Sharpincpdm mice demonstrated that hematopoietic stem cells
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transferred into sublethally irradiated, wild-type recipients did not
induce the CPDM phenotype, while reciprocal skin transplants
maintained the donor phenotype suggesting that skin-intrinsic
factors, rather than systemic effects, underlie the dermatitis [6,13].
However, the precise role of lymphocytes in the development of
the cutaneous and systemic inflammation has not been deter-
mined.
Eosinophils and macrophages are the predominant inflamma-
tory cell types in the skin of CPDM mice [6]. This corresponds
with an increased expression of type 2 cytokines and with an
increase in chitinase-like proteins including CHI3L4 (chitinase 3-
like 4), a hallmark of type 2 inflammatory responses [10,14].
Depletion of IL5 following treatment with neutralizing anti-IL5
antibodies or crosses with IL5-deficient mice decreased the
number of eosinophils, but did not ameliorate the dermatitis,
suggesting a limited role for eosinophils in disease development
[15]. On the other hand, systemic treatment with IL12 markedly
reduced the inflammation, suggesting that suppression of type 2
cytokines is beneficial [10].
Here we report studies aimed at more precisely defining the role
of lymphocytes and TH2 cytokines in CPDM inflammation.
SHARPIN-deficient mice were crossed with mice deficient in
recombination activating gene 1 (CByJ.Cg-Rag1tm1Mom, hereafter
referred to as Rag12/2 mice) that lack mature B and T
lymphocytes, and with IL4RA-deficient mice (BALB/c-IL4-
ratm1Sz/IL4ratm1Sz, hereafter Il4ra2/2) that lack the functional IL4
and IL13 receptor. Most of the work defining the role of Sharpin in
regulation of the NFKB and integrin pathways utilized the
C57BL/KaLawRij-Sharpincpdm/RijSunJ (Sharpincpdm) allele; howev-
er, a second spontaneous allelic mutation, CBy.OcB3-Sharpincpdm-
Dem, has been defined but the specifics of its phenotype had not
been characterized previously [7]. Comparison of the two strains
shows similar inflammation in Sharpincpdm-Dem mice but with a more
rapid onset compared with Sharpincpdm mice. Although mutations in
both Sharpin-deficient strains are in exon 1, and result in
truncation, strain-specific background modifying genes can also
affect the phenotype, therefore we used the Sharpincpdm-Dem mice for
the crosses, as the genetic background closely matches that of the
Rag12/2 and Il4ra2/2 mice. The studies reported here show that a
lack of lymphocytes did not affect the dermatitis, consistent with
an autoinflammatory disease, but markedly attenuated the
systemic inflammation. The absence of IL4 and IL13 signaling
abrogated expression of the chitinase-like protein CHI3L4 and
other type 2 associated chemokines, but resulted in more severe
cutaneous and systemic inflammation. This indicates that IL4,
IL13, or both act to suppress the inflammatory response in
SHARPIN-deficient mice.
Results
The phenotype of Sharpincpdm mice and their controls (Fig. 1 A,
B) has been reported in detail [6,8]. However, the Sharpincpdm-Dem
phenotype (Fig. 1 C, D) is less well characterized thus a detailed
phenotypic comparison of the two alleles was performed.
Sharpincpdm-Dem mice have a phenotype similar to the original
Sharpincpdm mice, with severe dermatitis, systemic inflammation,
and lymphoid organ defects. However, the skin and systemic
inflammatory changes have a more rapid onset in Sharpincpdm-Dem
mice than in Sharpincpdm mice as illustrated by shortened survival
curves (Fig. S1.) and a significant increase (p,.001) in epidermal
thickness and numbers of apoptotic keratinocytes by 4 weeks of
age (Fig. 1 U). Sharpincpdm mice usually require euthanasia by 10
weeks of age due to cutaneous ulceration, whereas Sharpincpdm-Dem
mice require euthanasia by 6–8 weeks of age. In addition,
Sharpincpdm-Dem mice have mild granulocytic inflammation of the
adrenal medulla which was not observed in Sharpincpdm mice (data
not shown). To assess the role of T and B cells in the pathogenesis
of the CPDM phenotype, Sharpincpdm-Dem mice were crossed with
Rag12/2 mutant mice, which lack mature B and T lymphocytes
due to inactivation of the V(D)J recombination activation gene 1
(Rag1) [16]. A second independent cross was made using mice
lacking the IL4 receptor alpha chain (Il4ra), a component of the
receptor for IL4 and IL13, crossed with Sharpincpdm-Dem mice.
IL4ra2/2 mice have a severely disrupted TH2 cytokine response
due to their inability to respond to both IL4 and IL13 [17,18]. In
each case, age, and sex matched compound mutant mice were
compared to Sharpincpdm-Dem, Rag12/2, or Il4ra2/2 single gene
mutants, and WT (+/+ or +/2) littermates as controls.
Histopathology of Sharpincpdm-Dem, Rag12/2;
Sharpincpdm-Dem, Il4ra2/2, and control mice
Skin. The dermatitis seen in Sharpincpdm-Dem mice and
Sharpincpdm-Dem, Rag12/2 double mutants was similar in its severity
(Fig. 2 B,D). Acanthosis, was present in both mutants with similar
diffuse orthokeratotic hyperkeratosis and focal parakeratosis.
Apoptotic keratinocytes were frequent within the epidermis and
hair follicle root sheaths. Occasional granulocytes were present in
the Malpighian layer and intracorneal and subcorneal pustules
were seen in the upper epidermis (p#0.001) (Fig. 2 F,H). The
epidermis was significantly thicker in the Sharpincpdm-Dem, Rag12/2
mutants when compared to Sharpincpdm-Dem or control animals
(Fig. 2 U). This exacerbation did not affect the frequency of
apoptosis in epidermal keratinocytes (Fig. 2 V) as evidenced by
similar numbers of cleaved CASP3/CASP9 positive cells (Fig. 2
L,P) when compared to Sharpincpdm-Dem (Fig. 2 j, n) though
both are higher in number than seen in WT controls (p#0.001)
(Fig. 2 I, M and K,O). Examination of skin from Sharpincpdm-Dem,
Rag12/2 mutants by transmission electron microscopy (TEM) also
revealed mitochondrial inclusions similar to those previously
described in Sharpincpdm mice (Fig. 2 Q, R, S, T). There was a
qualitatively similar accumulation of eosinophils, neutrophils, and
mononuclear cells in the dermis in both mutants.
The dermatitis in Sharpincpdm-Dem, Il4ra2/2 mice was much more
severe than in the Sharpincpdm-Dem mice (Fig. 3 B, D) and was
associated with significantly increased epidermal thicke-
ning(p#0.001) (Fig. 3 U) exceeding that in the Sharpincpdm-Dem,
Rag12/2 mutants, although in this case it was also accompanied by
significantly greater numbers (p#0.001) (Fig. 3 V) of cleaved
CASP3 and 9 positive, apoptotic cells (Fig. 3 L, P) compared to
Sharpincpdm-Dem (Fig. 3 J, N) or WT controls (Fig. 3 I, M, K, O).
As with both the Sharpincpdm-Dem mice and Sharpincpdm-Dem, Rag12/2
double mutants, TEM revealed abnormal inclusions in the
mitochondria of epidermal keratinocytes that increase in number
with disease progression (Fig. 3 Q, R, S, T). There was a
significant increase in eosinophil numbers in the skin or peripheral
blood of Sharpincpdm-Dem, Il4ra2/2 double mutants but it was not
significantly higher than the elevations seen in Sharpincpdm-Dem single
mutant mice. However, overall white blood cell count (WBC) and
neutrophil and lymphocyte counts were significantly increased in
the peripheral blood of double mutants compared to single
mutants or controls (p#0.001) (Fig. 4).
Systemic inflammation. Sharpincpdm-Dem mice had moderate
mixed cellular inflammation in portal triads and around the
central vein in the liver, around bronchioles and blood vessels in
the lung, and in the omentum in the peritoneal cavity, as
previously described for Sharpincpdm mice [6]. There was marked
inflammation in the large joints (shoulder, knee, and elbow) and
moderate inflammation in intervertebral joints. A few to moderate
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Figure 1. Mice with two different spontaneous mutant alleles of Sharpin show variations in onset of CPDM phenotype. At four weeks
of age, mutant mice homozygous for the Sharpincpdm (B) and Sharpincpdm-Dem (D) alleles both exhibit a similar chronic proliferative dermatitis
phenotype visible in H&E stained skin (Sharpincpdm F,J; Sharpincpdm-Dem H,L) when compared to WT littermates (E,I and G,K respectively). However, the
onset is much more rapid in Sharpincpdm-Dem mice as evidenced by the significantly increased epidermal thickening at four and six weeks (U) and by
the increased numbers of apoptotic cells (v) indicated by antibody detection of cleaved CASPASE 3 (P) and CASPASE 9 (T) when compared to
Sharpincpdm mutants (N,R) or WT mice (M,Q,O,S). All data are means +/2 SEM of N$3. (***Significance indicated by P#0.001).
doi:10.1371/journal.pone.0085666.g001
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Figure 2. Dermatitis was not reduced in the absence of functional lymphocytes in Sharpincpdm-Dem, Rag12/2 double mutants
compared to Sharpincpdm-Dem mice. Four week old Sharpincpdm-Dem, Rag12/2 double mutants and Sharpincpdm-Dem mice exhibit similar alopecia,
puritis, and flaking skin (B,D) not seen in WT controls (a,c). H&E of skin from Sharpincpdm-Dem, Rag12/2 double mutants (H) reveals epidermal
hyperplasia with ortho- and parakeratotic hyperkeratosis and the mixed dermal inflammatory cell infiltrates typically seen in Sharpincpdm-Dem mice (F)
when compared to age matched WT controls (E,G). However, systematic measurement of the epidermal width reveals that it is a small but significant
increase in total epidermal thickness (TE, basement membrane to top of the stratum corneum) and thickness of the Malphighian layer (basement
membrane to the base of the stratum corneum (BM-SC) in double mutant mice compared to controls (U). However, Sharpincpdm-Dem, Rag12/2 double
mutants did not exhibit significantly increased numbers (V) of apoptotic keratinocytes as indicated by immunohistochemical detection of cleaved
CASPASE 3 and 9 (J,N,L,P) when compared to controls (I,M,K,O). Examination by TEM reveals electron dense inclusions (arrows) in the mitochondria of
epidermal keratinocytes in compound mutant skin (T) similar to those seen in Sharpincpdm-Dem mice (R) which are absent in WT controls (Q,S). All data
are means +/2 SEM of N$4. (Significance indicated by * and*** P#0.001).
doi:10.1371/journal.pone.0085666.g002
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Figure 3. Loss of IL4RA signaling exacerbates the phenotype of Sharpin null mice. Four week old Sharpincpdm-Dem, Il4ra2/2 double mutants
(D) exhibit a greatly exacerbated phenotype when compared to Sharpincpdm-Dem mutants (B) or WT littermates (A,C). H&E of skin from Sharpincpdm-Dem,
Il4ra 2/2 double mutants (H) reveals significantly increased epidermal hyperplasia with ortho- and parakeratotic hyperkeratosis when compared to
Sharpincpdm-Dem mice (F) or to Il4ra2/2 (G) or WT (E) controls. Measurement of the epidermal width reveals that it is significantly increased in
compound mutant mice compared to Sharpincpdm-Dem and WT littermates both when measuring total epidermal thickness (TE, basement membrane
to top of the stratum corneum) and thickness of the Malphighian layer (basement membrane to the base of the stratum corneum (BM-SC) (U).
Sharpincpdm-Dem, Il4ra 2/2 double mutants also exhibited significantly increased numbers of apoptotic keratinocytes (V) as indicated by increased
immunohistochemical detection of cleaved CASPASE 3 and 9 (J,L, and N,P respectively) when compared to controls (i,m,k,o). Examination by TEM
reveals electron dense inclusions (arrows) in the mitochondria of epidermal keratinocytes of compound mutants, (t) similar to those seen in
Sharpincpdm-Dem mice (R) but absent in WT controls (Q,S). All data are means +/2 SEM of N$4. (Significance indicated by ***P#0.001).
doi:10.1371/journal.pone.0085666.g003
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numbers of granulocytes were present in the adrenal medulla of
the Sharpincpdm-Dem mice as early as 22 days of age, which was not
observed in the Sharpincpdm mice. Inflammation was greatly
attenuated in Sharpincpdm-Dem, Rag12/2 mice with no or minimal
inflammation present in the lungs, liver, or adrenal gland (Fig. 5
D, J, P, V), and mild to moderate inflammation in the joints. This
reduction was reflected in the peripheral blood by significant
reductions in numbers of WBC count and reduced percentages
and numbers of eosinophils in peripheral blood (Fig. 4 A)
Figure 4. Peripheral blood analysis of Sharpincpdm-Dem, Rag12/2 double mutant mice show a decline in systemic inflammation while
Sharpincpdm-Dem, Il4ra2/2 double mutant mice reveals increased systemic inflammation compared to Sharpincpdm-Dem and WT controls.
Advia peripheral blood analysis reveals significant reductions in white blood cell counts (WBC) in peripheral blood of four week old Sharpincpdm-Dem,
Rag12/2 double mutant mice when compared to matched WT controls. This change is reflected in significant declines in eosinophils but not
neutrophils. Differences in the number of lymphocytes reflect the lack of mature lymphocytes in Rag1null mice. White cell counts in peripheral blood
of Sharpincpdm-Dem, Il4ra2/2 double mutant mice were greatly increased when compared to single mutant and WT controls. This change is reflected in
significant increases in eosinophils, neutrophils, and lymphocytes. (Significance indicated by *P,0.05, ** P,0.01, and *** P,0.001).
doi:10.1371/journal.pone.0085666.g004
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although, as previously noted, this reduction in inflammation was
not mirrored in the skin.
In marked contrast, inflammation was much more severe in
Sharpincpdm-Dem, Il4ra2/2 double mutant mice than in Sharpincpdm-Dem
mice. There was extensive inflammation in the liver with focal to
coalescing areas of coagulative necrosis and mineralization (Fig. 5
L). The adrenal medulla was nearly completely effaced by
eosinophils (based on IHC staining for eosinophilic major basic
protein, data not shown) (Fig. 5 R). There was also more extensive
inflammation in the joints and peritoneal cavity than in Sharpincpdm-
Dem mice. Granulocytic inflammation in other tissues including the
salivary glands, meninges, and colon, was present in the
Sharpincpdm-Dem, Il4ra2/2 double mutant mice which was not
observed in either of the Sharpin allelic mutations. The increased
inflammation was reflected in the peripheral blood in the form of
significant increases in WBC counts, lymphocytes, eosinophils, and
neutrophils (Fig. 4 E, F, G, H).
Cutaneous cytokine expression in Sharpincpdm-Dem,
Il4ra2/2 mice
To determine the effect of loss of IL4 signaling on the expression
of type 1 and type 2 cytokines in Sharpin null mice, changes in
various cytokine mRNA levels were evaluated between WT;
Sharpincpdm-Dem; Il4ra2/2; and Sharpincpdm-Dem, Il4ra2/2 double
mutant mice. Total RNA was isolated from the skin of mice at 4
weeks of age and tested by qRT-PCR. As reported previously [10],
expression of Il4, Il5, and Il13 mRNA was significantly increased
in the skin of Sharpincpdm-Dem mice (Fig. 6 A, B, C). In compound
Sharpincpdm-Dem, Il4ra2/2 mice, Il4 expression was greatly increased
when compared with Sharpincpdm mice or WT controls while the
expression of Il13 mRNA was still elevated but not significantly
more than in Sharpincpdm-Dem mice. Expression of Ifng transcripts was
not significantly increased in the skin from Sharpincpdm mice and
Sharpincpdm-Dem, Il4ra2/2 mice (Fig. 6 D) suggesting that loss of
IL4RA signaling in Sharpin null mice did not skew the phenotype
towards production of type 1 cytokines.
In the absence of IL4 or IL13 in the Sharpincpdm-Dem, Il4ra2/2
mice, the expression of IL5 decreased (Fig. 6 B), but not enough
to reach significance when compared to with Sharpincpdm mice.
CCL 11 (eotaxin) and CCL24 (eotaxin-2) are important eosino-
phil-specific chemokines induced by IL4 and IL13 [19]. We
previously documented increased expression of CCL11 in the skin
of Sharpincpdm mice [20]. Here the expression of CCL11 and
CCL24 was assessed in Sharpincpdm-Dem, Il4ra2/2 mice to determine
if expression is affected by the absence of IL4 and IL13 signaling.
The expression of both chemokines increased in the skin of
Sharpincpdm-Dem mice, (p,0.001), was completely abrogated in
Sharpincpdm-Dem, Il4ra2/2 mice (Fig. 6 E, F) suggesting that the
hypereosinophilia was not dependent on IL4, IL13, or on IL4 and
IL13-induced chemokine expression in skin.
IL33 and TSLP, secreted by keratinocytes, promote a type 2
inflammatory response in skin [21,22] RT-PCR indicated that the
expression of TSLP and IL33 mRNA was significantly increased
in Sharpincpdm-Dem mice (p,0.001) (Fig. 6.) and that this upregula-
tion was maintained in Sharpincpdm-Dem, Il4ra2/2 double mutant
mice providing a possible explanation for the inflammation seen in
both mutants.
The presence of alternatively activated macrophages is a
hallmark of type 2 inflammation. One of the molecules typically
expressed by these macrophages is the chitinase-like protein
CHI3L4 [23] Increased expression of Chi3l4 mRNA was
previously observed in the skin of Sharpincpdm mice [14] and was
similarly observed in Sharpincpdm-Dem mice (Fig. 6 I). However, this
was completely abolished in Sharpincpdm-Dem, Il4ra2/2 mice (Fig. 6
I), indicating that IL4 and IL13 are critical for the induction of this
protein.
Figure 5. Systemic inflammation is decreased in Sharpincpdm-Dem, Rag12/2 double mutant mice but significantly increased in
Sharpincpdm-Dem, Il4ra2/2 double mutants compared to Sharpincpdm-Dem and WT controls. Four representative histological comparisons of
systemic inflammation in liver adrenal glands and lungs and lymphoid architecture in Peyer’s patches in four week old WT (A,G,M,S), Sharpincpdm-Dem
(B,H,N,T); Rag12/2(C,I,O,U); Il4ra2/2 (E,K,Q,W); Sharpincpdm-Dem, Rag12/2 (D,J,P,V); and Sharpincpdm-Dem, Il4ra2/2 (f,l,r,x) mice. Systemic inflammation is
generally attenuated in Sharpincpdm-Dem, Rag12/2 double mutant mice but exacerbated in Sharpincpdm-Dem, Il4ra2/2 double mutant mice compared to
Sharpincpdm-Dem controls.
doi:10.1371/journal.pone.0085666.g005
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Discussion
Two independent spontaneous mutations in exon 1 of the
Sharpin gene arose on two different inbred mouse strains, both
resulting in the complex phenotype of chronic proliferative
dermatitis (CPDM) mice. The Sharpincpdm allelic mutant mice have
a single base-pair deletion which occurred in mice on a C57BL/
KaLawRij background, a strain closely related to C57BL/6J based
Figure 6. Quantitative RT-PCR reveals significant changes in cytokine expression in Sharpincpdm-Dem, Il4ra2/2 double mutant mice
compared to single mutant and WT controls. RT-PCR was conducted on total RNA from four week old mouse skin taken from Sharpincpdm-Dem,
Rag12/2; Il4ra2/2; Sharpincpdm-Dem, Rag12/2; and Sharpincpdm-Dem, Il4ra2/2 mice (Significance indicated by * P,0.05, ** P,0.01, and *** P,0.001).
doi:10.1371/journal.pone.0085666.g006
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on skin graft histocompatibility [7] whereas Sharpincpdm-Dem mice
have a 14 base pair deletion and a single base pair substitution.
This latter allelic mutation is now maintained on the BALB/cByJ
congenic background [7]. Although the phenotypes of the two
strains of SHARPIN-deficient mice are qualitatively similar, the
development of the skin lesions and systemic inflammation was
accelerated in the Sharpincpdm-Dem mice resulting in a much more
severe phenotype at four weeks of age. The Sharpin mutations in
both strains result in a premature stop codon in exon 1 and
complete loss of SHARPIN expression [7]. This indicates that the
phenotypic differences are not caused by residual expression of
part of the SHARPIN protein, but rather by differences in strain-
specific genetic polymorphisms that affect the inflammatory
process. Because the Rag12/2 and Il4ra2/2 mice were on a
BALB/cJ or closely related BALB/cByJ congenic background,
crosses were set up with Sharpincpdm-Dem mice.
Loss of lymphocytes in Sharpincpdm-Dem, Rag12/2 mice did not
diminish the dermatitis consistent with the failure to induce the
CPDM phenotype by hematopoietic cell transfer [6]. However,
the systemic inflammation was markedly attenuated in the absence
of lymphocytes. This demonstrates that lymphocytes are not
necessary for the development of the cutaneous inflammation seen
in CPDM and suggests that the skin lesions are autoinflammatory
in nature. However, the lymphocyte dependence of the systemic
inflammation also suggests that this phenotype has an autoim-
mune component. Autoinflammatory diseases are caused by
activation of innate immune cells by endogenous or exogenous
stimuli in the absence of autoantibodies and self-reactive T cells.
Dermatitis is a common manifestation of autoinflammatory
diseases in human beings in particular those that are associated
with overexpression of IL1B (inflammasomopathies) and with
defects in the NFKB signaling pathways [12,24]. In the spectrum
of autoimmune, rheumatoid, and autoinflammatory diseases, a
mixture of autoinflammatory and autoimmune responses is
probably not uncommon, and the inflammation in the SHAR-
PIN-deficient mice is an example of such a complex pathogenesis.
The inciting event that leads to the cutaneous inflammation in
SHARPIN-deficient mice is not known. Mice with epidermal
specific deletions of IKK2 develop severe inflammatory skin
disease in a TNF-dependent manner, suggesting that NFKB
signaling is a critical component [25]. Likewise increased
keratinocyte apoptosis may contribute to inflammation, and is
also tied to NFKB, as supported by the increased sensitivity of
SHARPIN-deficient cells to TNF-induced necroptosis and the lack
of dermatitis in TNF-deficient Sharpincpdm mice [1]. Keratinocyte
cell death may lead to the release of pro-inflammatory danger
signals such as IL33, the expression of which was increased in the
skin of the mutant mice. Keratinocyte-specific deletion of caspase
8 and the FAS-associated death domain (FADD) adaptor protein
result in increased necroptosis of keratinocytes and cutaneous
inflammation that is strikingly similar to the dermatitis in
SHARPIN-deficient mice [26,27,28]. The inflammation in
FADD-deficient mice is not affected by the lack of lymphocytes
consistent with the autoinflammatory nature of the skin lesions
[28]. FADD-deficient keratinocytes had increased sensitivity to
TNF-induced cell death, and the development of the inflammation
was delayed in TNFR1- and TNF-deficient FADD-deficient mice
[28]. The dermatitis in mice with keratinocyte-specific deletion of
caspase 8 (Casp8tm1Wll) is characterized by accumulation of
eosinophils and macrophages and increased expression of type 2
cytokines similar to Sharpincpdm mice [26,27]. However, the
dermatitis in CASP8-deficient mice is not affected by absence of
TNF or IL1-receptor signaling [26], in contrast to Sharpincpdm mice
[1,29]. This suggests that the pathogenesis of the cutaneous
inflammation in SHARPIN-deficient mice is different from that in
CASP8 and FADD-deficient mice and illustrates how different
molecular pathways can lead to remarkably similar phenotypes.
Upregulation of CASP9 expression seen in the skin of SHARPIN
deficient mice could suggest an alternative, intrinsic apoptotic
mechanism.
The cutaneous inflammation in SHARPIN-deficient mice is
characterized by accumulation of eosinophils and overexpression
of type 2 cytokines. Previous work showed that this dermatitis was
not affected by depletion of IL5 and loss of eosinophils, but the
inflammation could be prevented by systemic administration of
IL12 [10,15]. To further examine the role of type 2 cytokines,
SHARPIN-deficient mice were crossed with Il4ra2/2 mice, which
abolished the function of IL4 and IL13. This effectively eliminated
the expression of Chi3l4 mRNA in the skin consistent with the
induction of these proteins in macrophages and mast cells by IL4
and IL13 [14,30,31]. In addition, Il4ra deletion decreased the
expression of Il5, though not to significant levels and abrogated
expression of the eosinophil-specific chemokines CCL11 and
CCL24. In spite of these changes, the dermatitis in Sharpincpdm-Dem,
Il4ra2/2 CPDM mice was more severe with similar numbers of
eosinophils. This indicates that other chemotactic factors are
responsible for the recruitment of eosinophils into the skin of the
double mutant mice. These findings are reminiscent of those in
NC/Nga mice that were crossed with STAT6-deficient mice [32].
NC/Nga mice develop dermatitis with eosinophils and mast cells
when housed in a conventional environment, usually associated
with ectoparasite infestations, more a form of atopic dermatitis
[33]. STAT6 is a transcription factor, pivotal for IL4 and IL13
signaling, and STAT6-deficient mice fail to develop a TH2
cytokine responses [34]. STAT6-deficient NC/Nga mice had
similar skin lesions as intact NC/Nga mice with eosinophils and
mast cells [32]. However, the authors reported that expression of
CCL11 and CCL24 was not affected by the STAT6 deficiency.
The exacerbated phenotype seen in Sharpincpdm-Dem, Il4ra2/2
mice was associated with increased apoptosis of keratinocytes as
well as degeneration and necrosis of hepatocytes. This may be
attributed to the anti-apoptotic role of IL4 signalling [35].
Overexpression of IL4 in mouse keratinocytes prevented UVB-
irradiation induced apoptosis, and in vitro treatment of normal
human epithelial cells with IL4 induced the expression of anti-
apoptotic proteins and reduced apoptosis by cytotoxic drugs
[36,37]. Increased apoptosis of keratinocytes in Sharpincpdm-Dem,
Il4ra2/2 mice may lead to greater release of pro-inflammatory
danger molecules and increased dermatitis. Hepatocytes of
Sharpincpdm mice had increased sensitivity to TNF-induced apop-
tosis [38], although degenerative changes and necrosis of
hepatocytes are not features of the phenotype of Sharpincpdm and
Sharpincpdm-Dem mice. However, in the absence of IL4RA-signaling
extensive hepatic coagulative necrosis and mineralization was
present, suggesting a greatly enhanced sensitivity of hepatocytes to
TNF. IL4 has direct anti-inflammatory effects by inhibiting the
secretion of pro-inflammatory cytokines by macrophages [39,40].
A recent study demonstrated that IL4 induces the differentiation of
newly recruited monocytes into anti-inflammatory M2 macro-
phages in a mouse model of allergic skin disease [41]. The
increased expression of CHI3L3/4 proteins in the skin of
Sharpincpdm mice is consistent with an M2 phenotype of macro-
phages [14], and the absence of these CHI3L3/4 in the skin of
IL4RA-deficient Sharpincpdm indicates a lack of anti-inflammatory
macrophages. Taken together, the exacerbated inflammation in
IL4RA-deficient Sharpincpdm-Dem mice can be attributed to increased
apoptosis of keratinocytes and abrogation of the anti-inflammatory
effect of IL4.
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What may account for the accumulation of eosinophils and
mast cells in the skin of IL4RA-deficient Sharpincpdm-Dem mice? A
possible explanation is the increased expression of the cytokines
TSLP and IL33 in the skin of SHARPIN-deficient mice which was
maintained in the absence of IL4RA. The expression of TSLP is
increased in keratinocytes of patients with atopic dermatitis and
keratinocyte-specific expression of TSLP induces atopic dermati-
tis-like inflammation in the skin of mice [42,43]. TSLP also plays a
critical role in a model of atopic dermatitis induced by topical
administration of calcipotriol that is independent of T lymphocytes
[44]. IL33 is a member of the IL1 family of cytokines and has been
identified as an important factor in allergic diseases [45]. It can
recruit and activate eosinophils directly. The expression of IL33 is
increased in human patients with atopic dermatitis and in mouse
models of atopic dermatitis [46]. The IL33 receptor is comprised
of ST2 and IL1 receptor associated protein (IL1RAP). A role for
IL33 in the dermatitis in SHARPIN-deficient mice is supported by
the attenuation of inflammation in Sharpincpdm mice in which
IL1RAP was deleted [29]. However, this needs confirmation as
IL1RAP is shared with other IL1-family receptors.
In conclusion, these studies determined that the cutaneous
inflammation in SHARPIN-deficient mice develops independently
of B and T lymphocytes and is autoinflammatory in nature,
whereas the systemic inflammation has a strong lymphocyte-
dependent component. Both cutaneous and systemic inflammation
are enhanced by loss of IL4 and IL13 signaling indicating that this
signaling pathway plays an anti-inflammatory role in SHARPIN-
deficient mice.
Materials and Methods
Generation and care of mice
Stocks of C57BL/KaLawRij-Sharpincpdm/RijSunJ; C.OcB3-
Sharpincpdm-Dem/Sharpincpdm-Dem; CByJ.Cg-Rag1tm1Mom, Sharpincpdm-Dem/
Sz; and C.Cg-Il4ratm1Sz, Sharpincpdm-Dem/Sz mice (The Jackson
Laboratory; Bar Harbor, ME) were maintained in the humidity,
temperature, and light cycle (12:12) controlled vivarium under
specific pathogen-free conditions (http://jaxmice.jax.org/
genetichealth/health_program.html). Mice were housed in
double-pen polycarbonate cages (330 cm2 floor area) at a
maximum capacity of four mice per pen. Mice were allowed
free access to autoclaved food (NIH 31, 6% fat; LabDiet 5K52,
Purina Mills, St. Louis, MO) and acidified water (pH 2.8–3.2).
All work was done with the approval of The Jackson
Laboratory Animal Care and Use Committee under approval
number 07005.
A second spontaneous Sharpin allelic mutation occurred on the
OcB3/Dem inbred strain at the Institute of Molecular Genetics,
Academy of Sciences, Czech Republic. This allele was moved on
the BALB/cByJ strain to create the congenic CBy.OcB3-
Sharpincpdm-Dem line. These mice and their BALB/cByJ controls
are also maintained at The Jackson Laboratory. The colony was
maintained by heterozygous matings and genotyped using the
primers D15Mit28. L: ATACACACGCACCCCCATAT; R:
CACCACTGACCAATGAGCC [7]. Rag12/2 mice were main-
tained as homozygotes as previously described [16] and were
genotyped by PCR using primers: 59 - TGGATGTGGAATGTG
TGCGAG –Mutant Forward; 59 - GAGGTTCCGCTAC-
GACTCTG- Wild type Forward; 59 - CCGGACAAGTTTTT-
CATCGT - Common Reverse. Il4ra2/2 mice were maintained as
homozygotes as previously described [18] and genotyped by PCR
using primers: 59 - CCAGACTGCCTTGGGAAAAG - Mutant
Forward, 59 –TGTGGGCTCAGAGTGACAT - Wild type
Forward, 59 - CAGGGAACAGCCCAGAAAAG- Common
Reverse. Sharpincpdm-Dem, Il4ra2/2 double mutant mice were
generated by intercrossing homozygous male BALB/c-Il4ratm1Sz/
J mice with heterozygous C.OcB3-Sharpincpdm-Dem females. Progeny
that genotyped as heterozygous for both alleles were then
intercrossed until the Il4ratm1Sz allele was fixed to homozygosity.
The colony was maintained by mating mice homozygous for the
Il4ratm1Sz allele and heterozygous for the Sharpincpdm-Dem allele. The
same strategy was used to generate mice homozygous for the
Rag1tm1Mom allele and heterozygous for the Sharpincpdm-Dem allele,
which were intercrossed to maintain the colony.
Phenotyping mutant mice
For each comparison conducted in this study, age matched
female and male mutant and control mice were collected,
euthanized by CO2 asphyxiation, and complete necropsies
performed as previously described [47]. Hematoxylin and eosin
(H&E) stained slides were examined by experienced board
certified veterinary anatomic pathologists (JPS, HH) all lesions
subjectively scored (normal, 0; mild, 1; moderate, 2; severe, 3;
extreme, 4) and data (with diagnosis and anatomic site) entered
into the Mouse Disease Information Database (MoDIS) [48].
These data were used to generate spread sheets for semi-
quantitative analysis. In addition, morphometric analyses of tissue
sections were done to determine epidermal thickness (dorsal
interscapular skin) along the linear length of sample. In each case
10 measurements were made within consecutive 250 um fields
along an H&E stained section of dorsal skin from each mouse.
Total epidermal thickness (TE, basement membrane to top of the
stratum corneum) and thickness of the Malphighian layer
(basement membrane to the base of the stratum corneum (BM-
SC) were done in vertical sections which were taken in areas
meeting the specific critieria of being intrafollicular regions of the
epidermis, with the entire length of the hair follicle in the field for
consistent orientation. Measurements were done at 4006magni-
fication using a DP70 digital camera on a BH2 photomicroscope
(Olympus, Tokyo, Japan) and DP controller 3.2 software
(Olympus, Center Valley, PA).
Hematology
200 ul of whole blood was collected in in heparinized tubes.
The uncoagulated blood was run without separation on a Siemens
Advia 2120 Hematology Analyzer (Siemens Healthcare Diagnos-
tics Inc; Tarrytown, NY).
Immunohistochemistry
Cleaved Caspase 3 (CASP3) (Cat#9661, Cell Signalling
Technologies; Danvers, MA) and cleaved Caspase 9 (CASP9)
(Cat# NB100-56118, Novus Biologicals; Littleton, CO) positive
cells were identified by immunohistochemistry in paraffin embed-
ded mouse skin fixed with Fekete’s acid alcohol formalin as
previously described [49] using a using a Leica Autostainer
ST5020 (Leica Microsystems; Buffalo Grove, IL). Counts were
made of the number of CASP3 or CASP9 positive cells within a
250 um length of dorsal skin epidermis. Ten measurements were
taken from each mouse.
Quantitative real-time RT-PCR (qRT-PCR)
The expression of Il4, Il5, Il13, Ifng, Ccl11, Ccl24, and Cxcl10
mRNA in the skin of 4-week old mice was determined by qRT-
PCR (Renninger et al., 2005). Skin from 4 weeks of age/sex
matched mice was collected and stored in RNALater (Qiagen,
Valencia, CA) at 280uC until samples from all replicates were
collected. RNA was then extracted using a PureLink RNA Mini
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Kit (Invitrogen, Grand Island, NY). For each qRT-PCR, a 15 ul
reaction was run with 7.5 ul Taqman One-Step RT-PCR Master
Mix 2X (Life Technologies, Grand Island, NY), 0.4 ul, Space
between number and measurement unit as here or not as in most
examples in the paper) 406Multiscribe and Rnase Inhibitor Mix,
0.75 ul of 206Assays on Demand Taqman primer and probe set
and 100 ng RNA. The qRT-PCR was performed in a Mastercy-
clerH realplex4 (Eppendorf, Hauppauge, NY) programmed at 40
cycles of 42 C for 50 minutes, 90 C for 10 minutes, 95 C for
15 seconds, 60 C for 1 minute, and 72 C for 1 minute. The Ct
values for each chemokine were normalized by subtracting the Ct
values for the housekeeping gene Actb (Delta Ct). The relative fold-
change in mRNA expression between wild-type mice and mutant
mice was calculated by the 22(delta-delta Ct) [50].
Statistical analysis
All analyses were completed using JMP (SAS Institute Inc, Cary
NC) linear regression models in lieu of analysis of variance
(ANOVA). The effect of genotype was evaluated per phenotype
(hematological and skin morphometrics). Prior to testing, each
dataset was analyzed to establish conformation with linear
regression assumptions. Where necessary, data transformation
(i.e., logarithm or square root) was applied to meet assumption
criteria. Genotype factor significance (p-value,0.05) indicating
that at least two genotype levels differ with respect to their
phenotypic measurements was established subject to a Tukey HSD
post-hoc test (adjusted p-value,0.05) to identify significant differ-
ences between individual factor levels. Kaplan-Meyer Plots for
lifespan were done using n$5 mice for each genotype based on
length of life from birth until The Jackson Laboratory ACUC
regulations required euthanasia for morbidity.
Supporting Information
Figure S1 Kaplan Meyer plots of lifespan reveals
significantly reduced survival rates in Sharpincpdm-Dem,
Il4ra2/2 mice. Sharpincpdm-Dem, Il4ra2/2 mice have reduced
average survival when compared to Sharpincpdm-Dem, Rag12/2
compound mutants and to Sharpincpdm-Dem or Sharpincpdm mutants.
Rag12/2, Il4ra2/2, and WT (Sharpincpdm-Dem/+, or Sharpincpdm/+)
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